ORAMED PHARMACEUTICALS INC. 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Li Xiaopeng
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-30+16,773→ 16,773 totalExercise: $7.77Exp: 2027-06-30→ Common Stock (16,773 underlying)
Footnotes (1)
- [F1]The Stock Option will vest in 3 equal installments of 5,591 on each of December 31, 2017, December 31, 2018 and December 31, 2019.